Irvine-based LensGen Inc. has closed $21 million series A financing, with an option to expand the financing commitment by an additional $5 million.
The financing was led by the corporate venture investment arm of technology and med-tech company HOYA Group in Tokyo, Japan and included participation from Relativity Healthcare Partners.
LensGen develops implantable intraocular lens for patients with presbyopia, an age-related vision condition in which the eye loses its flexibility making it difficult to focus on close objects.
The medical device company makes lens that is designed to mimic the eye’s ability to change shape—curvature—and adjust focus.
